Anping Li

Affiliations: 
The Wistar Institute, USA 
Google:
"Anping Li"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Xiao H, Zeng J, Li H, et al. (2019) Correction: MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis. Oncotarget. 10: 7183-7184
Yu S, Li A, Liu Q, et al. (2017) Recent advances of bispecific antibodies in solid tumors. Journal of Hematology & Oncology. 10: 155
Liu Q, Yu S, Li A, et al. (2017) Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 39: 1010428317712445
Pan YN, Li AJ, Chen XM, et al. (2016) Coronary Computed Tomographic Angiography at Low Concentration of Contrast Agent and Low Tube Voltage in Patients with Obesity: A Feasibility Study. Academic Radiology
Huang Q, Zhou C, Chen X, et al. (2015) Prodrug AST-003 Improves the Therapeutic Index of the Multi-Targeted Tyrosine Kinase Inhibitor Sunitinib. Plos One. 10: e0141395
Rao L, Bu LL, Xu JH, et al. (2015) Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance. Small (Weinheim An Der Bergstrasse, Germany)
Xiao H, Tang K, Liu P, et al. (2015) LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma. Oncotarget
Gumireddy K, Li A, Chang DH, et al. (2015) AKAP4 is a circulating biomarker for non-small cell lung cancer. Oncotarget
Xiao H, Zeng J, Li H, et al. (2015) MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis. Oncotarget. 6: 13201-15
Chen K, Yu G, Gumireddy K, et al. (2015) ZBRK1, a novel tumor suppressor, activates VHL gene transcription through formation of a complex with VHL and p300 in renal cancer. Oncotarget. 6: 6959-76
See more...